News

Find News

Filter articles

Showing 1 to 10 of 3082 results

Janssen sues Mylan to block generic of schizophrenia drug

US29-09-2020Muireann Bolger

A Johnson & Johnson company, Janssen Pharmaceuticals, is seeking a court order blocking Mylan from making copies of its schizophrenia treatment, Invega Trinza, until its patent expires in 2036.

Appeals court sides with Pfizer, Merck KGaA in $5bn suit

US29-09-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit has sided with EMD Serono and Pfizer over the invalidation of a multiple sclerosis drug patent, in a defeat for biotech company Biogen.

MSD petitions SCOTUS over $2.5bn patent verdict

US28-09-2020Sarah Morgan

MSD subsidiary Idenix has urged the US Supreme Court to review the overturning of a record $2.5 billion verdict against Gilead Sciences.

PTAB cancels Imbruvica patent claims in blow for AbbVie

US25-09-2020Rory O'Neill

The US Patent Trial and Appeal Board has invalidated parts of an AbbVie patent covering blood disease drug Imbruvica.

Genmab locked in J&J royalty payments dispute

Belgium, Denmark, US24-09-2020Sarah Morgan

Danish biotech Genmab has commenced binding arbitration of two matters with Janssen Biotech, a Johnson & Johnson company, over royalty payments for a cancer drug.

ERS Genomics appoints vice-president of IP

Ireland, US23-09-2020Sarah Morgan

ERS Genomics, the company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, has appointed Michael Arciero as vice-president of IP and commercial development.

Bausch Health settles with Sun Pharma

Canada, India, US23-09-2020Sarah Morgan

Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.

Illumina to acquire Jeff Bezos-backed cancer testing company

US23-09-2020Sarah Morgan

Genetic sequencing company Illumina is set to pay $8 billion for Grail, a cancer detection company that was spun out of Illumina four years ago.

BMS and Dr Reddy’s settle Revlimid suit with generics licence

US22-09-2020Rory O'Neill

Bristol Myers Squibb and Celgene have settled their patent litigation with Dr Reddy’s over a generic version of cancer drug Revlimid.

Gilead accused of illegally paying to delay HIV drug competition

US22-09-2020Muireann Bolger

Biopharmaceutical company Gilead is being sued for allegedly scheming to prevent a generic rival from releasing a competing version of its HIV drug Truvada, according to a class action lawsuit filed by investors in the drug manufacturer.

Showing 1 to 10 of 3082 results

LSIPR